Radiation dose ≥54 Gy and CA 19–9 response are associated with improved survival for unresectable, non-metastatic pancreatic cancer treated with chemoradiation

Radiation dose ≥54 Gy and CA 19–9 response are associated with improved survival for unresectable, non-metastatic pancreatic cancer treated with chemoradiation

<p>Abstract</p> <p>Background</p> <p>Unresectable pancreatic cancer (UPC) has low survival. With improving staging techniques and systemic therapy, local control in patients without metastatic disease may have increasing importance. We investigated whether the radiation...

Full description

Bibliographic Details
Main Authors: Golden Daniel W, Novak Caroline J, Minsky Bruce D, Liauw Stanley L
Format: Article
Language:English
Published: BMC 2012-09-01
Series:Radiation Oncology
Subjects:
Pancreas cancer
Radiotherapy dosage
Chemotherapy
CA-19-9 antigen
Online Access:http://www.ro-journal.com/content/7/1/156

Similar Items

Similar Items